Dr. Gazit is focusing on how to develop targeted treatment of cancer cells
using hematopoietic stem cells — stem cells used in cancer treatment because of their ability to divide and form new and different kinds of blood cells.
Basically what was happening when
you use a hematopoietic stem cell to correct an inherited metabolic disease is that through engraftment of that cell you are allowing that cell to become the replacement source for the missing enzyme or other factor - almost like a cellular form of gene therapy or, as I call it, «poor man's gene therapy».
Not exact matches
One of the most popular models is the immunodeficient nonobese diabetic severe combined immunodeficiency (NOD scid) gamma (NSG) transgenic mouse line, which can be endowed with a humanized immune system
using CD34 +
hematopoietic stem cells.
«Immunotherapy drug nearly eliminates severe acute graft - versus - host disease: Drug
used to treat rheumatoid arthritis improves survival after
hematopoietic stem cell transplant.»
Scientists at the Helmholtz Zentrum München and their partners at ETH Zurich and the Technical University of Munich (TUM) have now
used it to determine the development of
hematopoietic stem cells in advance.
These so - called
hematopoietic stem cells (from Greek meaning «to make blood») have been reliably
used over the past 40 years to seed bone marrow transplants in the treatment of some cancers and immune disorders.
The transplantation of isolated human
hematopoietic stem cells is
used in the treatment of anemia, immune deficiencies and other diseases, including cancer.
Because of their remarkable ability to renew themselves and differentiate into other cells,
hematopoietic stems cells are the focus of intense research and have been
used to treat many diseases and conditions.
Zhao and his colleagues are also investigating whether a megakaryocyte niche can be
used to help expand human
hematopoietic stem cells in vitro and
stem cell transplantation for patients.
The discovery could provide insight for
using megakaryocyte - derived factors, such as TGF - B1 and FGF1, clinically to facilitate regeneration of
hematopoietic stem cells, he adds.
Although many immunosuppressive strategies have failed, the recent
use of autologous
hematopoietic stem and progenitor cell (HSPC) transplantation has shown therapeutic promise.
Lastly, two sessions dedicated to disease modeling and cell therapy, respectively, will highlight ongoing attempts to study and treat diseases
using stem cells from the
hematopoietic and neural systems.
It would have been more appropriate to note that their review targeted
hematopoietic stem cell transplantation because embryonic
stem cells are not yet ready for clinical
use.
Several gene therapy clinical trials
using gene - modified
hematopoietic stem cells have shown therapeutic efficacy in multiple disease areas.
Plerixafor has been approved by the FDA as the first small - molecule CXCR4 antagonist for
use in combination with granulocyte - colony stimulating factor (GCSF) to mobilize
hematopoietic stem cells to the bloodstream for collection and subsequent autologous transplantation in patients with non-Hodgkin's lymphoma and multiple myeloma.
Under his direction, plasmid DNA, CAR - T - cells, regulatory T - cells, engineered
stem cell grafts and gene modified
hematopoietic stem cell products have been manufactured and released for
use in Phase I / II clinical trials.
Before coming to Columbia she worked as a technician in Leonard Zon's lab at Harvard Medical School
using zebrafish as a model for investigating the molecular mechanisms of
hematopoietic stem cell differentiation and self renewal.
Treating HIV: Although
hematopoietic stem cells have been used since World War II to treat victims of radiation, a potential, significant new application was reported just last year: Hematopoietic stem cells were used to successfully treat a patient with HIV, although the procedure is currently risky and much additional research is necessary for it to be widely accep
hematopoietic stem cells have been
used since World War II to treat victims of radiation, a potential, significant new application was reported just last year:
Hematopoietic stem cells were used to successfully treat a patient with HIV, although the procedure is currently risky and much additional research is necessary for it to be widely accep
Hematopoietic stem cells were
used to successfully treat a patient with HIV, although the procedure is currently risky and much additional research is necessary for it to be widely accepted and
used.
Use of a lower dose of rabbit anti — T - lymphocyte globulin (ATLG) was superior to a higher dose in children with hematologic malignancies undergoing allogeneic
hematopoietic stem cell transplantation (HSCT) from an unrelated donor, according to the results of a study published in Lancet Oncology.
The FDA has approved the
use of
stem cell - based products, including cord blood - derived
hematopoietic progenitor cells (blood forming
stem cells) for many diseases.
Hematopoietic Stem Cells: The first time stem cells were successfully used to treat patients was during World War
Stem Cells: The first time
stem cells were successfully used to treat patients was during World War
stem cells were successfully
used to treat patients was during World War II.
Efficient gene transfer into rhesus repopulating
hematopoietic stem cells
using a simian immunodeficiency virus - based lentiviral vector system.
Hematopoietic stem cells (HSCs) have long been
used to provide lifesaving treatments for patients with malignant and non-malignant hematological disorders.
Today
hematopoietic stem cells are one of the few types of adult
stem cells that are widely
used clinically.
Many have
used viruses to convert adult cells to
stem cells and to carry a normal HBB gene to infect and repair
hematopoietic stem cells —
stem cells that give rise to all blood cells.
More recently, recombinant TAT - HOXB4 was
used to expand
hematopoietic stem cells up to 20-fold without the need for viral gene transfection, avoiding the potential hazards of inducing lymphoproliferative disease [15].
One approach in clinical trials is to wipe out the patient's immune system
using strong doses of chemotherapy with antibodies and then
use their own previously banked
hematopoietic stem cells (blood forming
stem cells) to regenerate the blood system.
Microarray profiling
using the Affymetrix Mouse Genome 430 2.0 array, defines sets of genes that are specific to bone marrow - derived
hematopoietic stem cells and their different immunological progeny.
One type of
stem cell transplant, autologous
hematopoietic stem cell transplantation,
uses stems cells from your own bone marrow, or from external umbilical cord blood.
New Insights on Pain and Opioid
Use in People With Sickle Cell Disease After
Hematopoietic Stem Cell Transplant (March 12, 2018)